News

AddToAny

Google+ Facebook Twitter Twitter

Early disease detection using DNA droplets

A group of scientists has developed a computational DNA droplet with the ability to recognise specific combinations of chemically synthesised microRNAs (miRNAs) that act as biomarkers of tumours.

Using these miRNAs as molecular input, the droplets can give a DNA logic computing output through physical DNA droplet phase separation.

Professor Masahiro Takinoue from Tokyo University of Technology said: “Even though biological systems regulate their functions by combining biosensing with molecular logical computation, no literature is available on integration of DNA droplet with molecular computing.”

Developing this DNA droplet required a series of experiments. First, they designed three Y-shaped DNA nanostructures called Y-motifs A, B, and C with three sticky ends to make A, B, and C DNA droplets.

The team used linker molecules to join the A droplet with B and C droplets. They evaluated the “AND” operation in the AB droplet mixture by introducing two input DNAs.

They then introduce breast cancer tumour markers, miRNA-1 and miRNA-2, to the AC droplet mixture as inputs for the AND operation. The AND operation was successful, implying that the computational DNA droplet identified the miRNAs.

bit.ly/3Q5IJnq

Image credit | iStock

 

Related Articles

The big question: Are we entering a new era in which mRNA vaccines are the future?

In May, AstraZeneca began the worldwide withdrawal of its COVID-19 vaccine, due to a “surplus of updated vaccines” that target new variants. Then in June, Moderna announced positive late-stage trial results for its single COVID/flu combination vaccine, mRNA-1083. On the back of this, we look at the future impact of mRNA vaccines.

Breast cancer CREDIT - Science Photolibrary- C0584739

Predicting the return of breast cancer

Dr Isaac Garcia-Murillas discusses a new blood test that can predict if breast cancer will return years before the disease shows on scans.

Restless leg syndrome - CREDIT Science Photolibrary- C0309748

Study points to potential treatments for restless leg syndrome

Scientists have discovered genetic clues to the cause of restless leg syndrome. The discovery could help identify those individuals at greatest risk of the condition and point to potential ways to treat it.

Stem cell transplant and cellular therapy lab

My lab: stem cell transplant and cellular therapy lab

Advanced Specialist Biomedical Scientist Mel Green gives a guided tour of the stem cell transplant lab at Nottingham University Hospitals.

Top